Visit Consumer Site Visit Professional Site
A Sonova brand

Unitron news

Oct 01, 2013
Unitron Introduces Moxi² and Quantum² with Fle

Next generation of Unitron’s popular hearing instruments deliver new styles and advancements to create the best first fit experience


October 1st, 2013 - Kitchener, Canada – Unitron today announced the next generation of its popular Moxi™ and Quantum™ hearing instruments built on the Era™ platform. Along with new styles, Moxi² and Quantum² create a best first fit experience for patients, offering evolved natural sound and a full set of features that provide more effortless listening across four technology levels.


Create the best first fit experience for your patient
Both product families incorporate signature technologies that deliver the ease of listening and clarity of speech necessary to create a best first fit experience and overall increased patient satisfaction. SmartFocus™ 2 includes enhancements that offer a new level of speech intelligibility in noise and limit the distracting noises that impact more than 90 per cent of a patient’s hearing experience. Unitron’s Automatic Adaptation Manager is proven to keep new wearers more satisfied by starting them at their preferred listening levels, then transitioning them to the amplification they need, gradually, comfortably and automatically.


Fresh new styles for maximum flexibility
Moxi² and Quantum² product families introduce fresh new styles providing hearing healthcare professionals (HHCPs) with even greater flexibility to meet patient needs. The Moxi² family includes a choice of three receiver-in-canal (RIC) styles, including the Moxi² Kiss and the new robust Moxi² Dura, while the Quantum² family offers a complete selection of performance BTEs and ITEs, including a new BTE.


Increase patient confidence with FLEX
Moxi² and Quantum² are also available with Unitron FLEX:TRIAL™, the industry’s first and only flexible and risk-free hearing trial solution aimed at improving patient satisfaction and hearing instrument adoption. With FLEX:TRIAL, HHCPs can fit patients with a same day trial of technology they recommend, at no cost or obligation, allowing them to experience the benefits of hearing instruments in their daily lives. Highly successful since its introduction to market a year ago, FLEX:TRIAL is providing HHCPs with unprecedented ability to meet patient expectations while enhancing their business.


“As part of our ongoing commitment to customer success, we are continually working with hearing healthcare providers to understand their needs so that we can ensure we are delivering the products and services that will enhance their business and enable patient success,” says Jan Metzdorff, President, Unitron. “This critical customer feedback has helped us raise the bar of excellence with Moxi² and Quantum² product families with a focus on creating the best first fit experience possible. Our comprehensive line up of styles provides hearing healthcare providers with more choice to meet patient needs and the latest advancements in natural sound quality offers patients an easy, comfortable listening experience.”

1 AudiologyNow! 2013, Acclimatization to Amplification Through Gradual Gain Model Adjustment; Presenter : Donald Hayes, PhD, Unitron Hearing Ltd. Contributors: John Pumford, AuD, Unitron Hearing Ltd.; Paula Folkeard, AuD, Western University



About Unitron
Unitron is a global company that understands the hearing healthcare business is built on strong, personal relationships. We work closely with hearing healthcare professionals to improve the lives of people with hearing loss. A member of the Sonova Group, Unitron has a proven track record of developing hearing innovations that provide natural sound with exceptional speech understanding. Headquartered in Canada, Unitron distributes its full line of hearing instruments to customers in over 60 countries. For more information, please visit us on the web at unitron.com/us.


Ann Marie Lang
Corporate Media Relations
(519) 895-0100 ext. 2104


This website or application uses cookies.  In order to find out more about our use of cookies, please consult our Cookie PolicyFor general information about cookies, please visit www.allaboutcookies.org.